134 related articles for article (PubMed ID: 25891893)
1. Transferrin receptors and glioblastoma multiforme: Current findings and potential for treatment.
Voth B; Nagasawa DT; Pelargos PE; Chung LK; Ung N; Gopen Q; Tenn S; Kamei DT; Yang I
J Clin Neurosci; 2015 Jul; 22(7):1071-6. PubMed ID: 25891893
[TBL] [Abstract][Full Text] [Related]
2. Effects of cell proliferation on the uptake of transferrin-bound iron by human hepatoma cells.
Lee AW; Oates PS; Trinder D
Hepatology; 2003 Oct; 38(4):967-77. PubMed ID: 14512884
[TBL] [Abstract][Full Text] [Related]
3. Analyses for binding of the transferrin family of proteins to the transferrin receptor 2.
Kawabata H; Tong X; Kawanami T; Wano Y; Hirose Y; Sugai S; Koeffler HP
Br J Haematol; 2004 Nov; 127(4):464-73. PubMed ID: 15521925
[TBL] [Abstract][Full Text] [Related]
4. Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends.
Choudhury H; Pandey M; Chin PX; Phang YL; Cheah JY; Ooi SC; Mak KK; Pichika MR; Kesharwani P; Hussain Z; Gorain B
Drug Deliv Transl Res; 2018 Oct; 8(5):1545-1563. PubMed ID: 29916012
[TBL] [Abstract][Full Text] [Related]
5. Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo.
Kawabata H; Germain RS; Vuong PT; Nakamaki T; Said JW; Koeffler HP
J Biol Chem; 2000 Jun; 275(22):16618-25. PubMed ID: 10748106
[TBL] [Abstract][Full Text] [Related]
6. The Cytoplasmic domain of transferrin receptor 2 dictates its stability and response to holo-transferrin in Hep3B cells.
Chen J; Enns CA
J Biol Chem; 2007 Mar; 282(9):6201-9. PubMed ID: 17202145
[TBL] [Abstract][Full Text] [Related]
7. Elevated levels of transferrin receptor 2 mRNA, not transferrin receptor 1 mRNA, are associated with increased survival in acute myeloid leukaemia.
Nakamaki T; Kawabata H; Saito B; Matsunawa M; Suzuki J; Adachi D; Tomoyasu S; Phillip Koeffler H
Br J Haematol; 2004 Apr; 125(1):42-9. PubMed ID: 15015967
[TBL] [Abstract][Full Text] [Related]
8. Distinct cellular responses induced by saporin and a transferrin-saporin conjugate in two different human glioblastoma cell lines.
Cimini A; Mei S; Benedetti E; Laurenti G; Koutris I; Cinque B; Cifone MG; Galzio R; Pitari G; Di Leandro L; Giansanti F; Lombardi A; Fabbrini MS; Ippoliti R
J Cell Physiol; 2012 Mar; 227(3):939-51. PubMed ID: 21503892
[TBL] [Abstract][Full Text] [Related]
9. Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma.
Staquicini FI; Ozawa MG; Moya CA; Driessen WH; Barbu EM; Nishimori H; Soghomonyan S; Flores LG; Liang X; Paolillo V; Alauddin MM; Basilion JP; Furnari FB; Bogler O; Lang FF; Aldape KD; Fuller GN; Höök M; Gelovani JG; Sidman RL; Cavenee WK; Pasqualini R; Arap W
J Clin Invest; 2011 Jan; 121(1):161-73. PubMed ID: 21183793
[TBL] [Abstract][Full Text] [Related]
10. Transferrin receptor 2 is frequently expressed in human cancer cell lines.
Calzolari A; Oliviero I; Deaglio S; Mariani G; Biffoni M; Sposi NM; Malavasi F; Peschle C; Testa U
Blood Cells Mol Dis; 2007; 39(1):82-91. PubMed ID: 17428703
[TBL] [Abstract][Full Text] [Related]
11. Immune check-point in glioblastoma multiforme.
De Felice F; Pranno N; Marampon F; Musio D; Salducci M; Polimeni A; Tombolini V
Crit Rev Oncol Hematol; 2019 Jun; 138():60-69. PubMed ID: 31092387
[TBL] [Abstract][Full Text] [Related]
12. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis.
Fleming RE; Migas MC; Holden CC; Waheed A; Britton RS; Tomatsu S; Bacon BR; Sly WS
Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2214-9. PubMed ID: 10681454
[TBL] [Abstract][Full Text] [Related]
13. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
[TBL] [Abstract][Full Text] [Related]
14. Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment.
Ramalho MJ; Sevin E; Gosselet F; Lima J; Coelho MAN; Loureiro JA; Pereira MC
Int J Pharm; 2018 Jul; 545(1-2):84-92. PubMed ID: 29715532
[TBL] [Abstract][Full Text] [Related]
15. The role of Hfe in transferrin-bound iron uptake by hepatocytes.
Chua AC; Herbison CE; Drake SF; Graham RM; Olynyk JK; Trinder D
Hepatology; 2008 May; 47(5):1737-44. PubMed ID: 18393371
[TBL] [Abstract][Full Text] [Related]
16. Transferrin receptor 2: evidence for ligand-induced stabilization and redirection to a recycling pathway.
Johnson MB; Chen J; Murchison N; Green FA; Enns CA
Mol Biol Cell; 2007 Mar; 18(3):743-54. PubMed ID: 17182845
[TBL] [Abstract][Full Text] [Related]
17. Gallium Maltolate Disrupts Tumor Iron Metabolism and Retards the Growth of Glioblastoma by Inhibiting Mitochondrial Function and Ribonucleotide Reductase.
Chitambar CR; Al-Gizawiy MM; Alhajala HS; Pechman KR; Wereley JP; Wujek R; Clark PA; Kuo JS; Antholine WE; Schmainda KM
Mol Cancer Ther; 2018 Jun; 17(6):1240-1250. PubMed ID: 29592883
[TBL] [Abstract][Full Text] [Related]
18. Characterization of hepcidin response to holotransferrin in novel recombinant TfR1 HepG2 cells.
Mehta K; Busbridge M; Renshaw D; Evans RW; Farnaud S; Patel VB
Blood Cells Mol Dis; 2016 Oct; 61():37-45. PubMed ID: 27667164
[TBL] [Abstract][Full Text] [Related]
19. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.
Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J
Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889
[TBL] [Abstract][Full Text] [Related]
20. Predominantly post-transcriptional regulation of activation molecules in chronic lymphocytic leukemia: the case of transferrin receptors.
Chiotoglou I; Smilevska T; Samara M; Likousi S; Belessi C; Athanasiadou I; Stavroyianni N; Samara S; Laoutaris N; Vamvakopoulos N; Anagnostopoulos A; Fassas A; Stamatopoulos K; Kollia P
Blood Cells Mol Dis; 2008; 41(2):203-9. PubMed ID: 18621559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
